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1. Introduction  
Soybeans (Glycine Max) are one of the oldest crops cultivated around the world, and in Asia 
soyfoods have been consumed for more than 1000 years. The soybean was popularized 
because of its high content of protein and good percentage of lipids. World consumption of 
soybeans in 2008 was over 221 million metric tons, with approximately 50% of this supply 
coming from US production, where over 77 million ha are planted annually. Soybeans are 
desired in the market as a source of protein and oil. Nowadays, soy has a huge economic 
importance because the beans are very versatile and can be used not only for human and 
animal nutrition but also for industrial products (Clemente & Cahoon 2009). 
Many beneficial effects of soy components such as soy protein, isoflavones, phytosterols, 
inositol hexaphosphate and saponins have been suggested, including the beneficial role for 
inhibition of tumor development in animal models (Hawrylewicz, Zapata et al. 1995). This 
has stimulated, in only the last 30 years, soybean introduction into western cultures and 
diets  as different sub-products (Golbitz 1995). These products are usually fermented 
(tempeh, miso, soy sauces, natto, fermented tofu) or non-fermented (fresh soybeans, whole 
dry soybeans, soy nuts, soy sprouts, whole-fat soy flour, soymilk, tofu, soy protein, soy oil). 
One of the most used nonfermented subproduct is the soybean oil. The oil represents 
approximately 20% of the grain and is influenced by both genotype and environmental 
factors, and in some countries this is the main sub-product utilized in the diet (Clemente & 
Cahoon 2009).  
Soybean oil is a representative source of lipids in human nutrition. There are proposed 
mechanisms that explain lipids involvement in cancer development, especially colorectal 
cancer (CRC). Thus, comparing soybean oil composition with other oils is a discussion that 
is relevant in the context of CRC, once this is a public health concern. 
2. Cancer epidemiology 
Cancer is a major public health problem in the United States (US) and in others parts of the 
world (Jemal, Siegel et al. 2010). According to GLOBOCAN 2008 statistics, CRC is the third 
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most incidental type of cancer in men and the second in women worldwide and accounts for 
8% of all cancer deaths, making it the fourth most common cause of death from cancer. 
Almost 60% of the cases occur in developed regions (Ferlay, Shin et al. 2010 ). 
Changes in the incidence of CRC have been observed worldwide, with a statistically 
significant increase in its incidence from 1983-87 to 1998-2002. Europe, Slovakia, Slovenia 
and Czech Republic have shown the largest increase (>45% for men and 25% for women). In 
countries of Western Europe (France, Italy, England, Germany and Switzerland) the CRC 
incidence has remained stable or increased only slightly, except for Spain which presented 
large increases. In Asia, the largest increases were observed in Japan, Kuwait and Israel, and 
some areas with large increases in incidence, such as India, Thailand and Kuwait, still 
maintained relatively low incidence rates. In China, incidence increased by 50% in Shanghai 
compared with 10% in Hong Kong. In contrast, the incidence rates decreased significantly 
for the US population of both sexes, as well as for Canadian and New Zealand women. In 
general the increase was largely confined to economically transitioning countries and 
stabilized in the majority of developed countries, decreasing only in the US. The technology 
available for CRC screening can influence incidence rates since techniques such as 
colonoscopy are able to reduce this incidence through the removal of precancerous polyps. 
In the US, colonoscopy has been the most used screening test, which may be contributing to 
the decreased incidence rates (Center, Jemal et al. 2009; Murphy, Devesa et al. 2011). 
Colorectal cancer is considered a multifactorial disease. The fact that cancer incidence and 
mortality rates vary dramatically worldwide, and that population migrating from a low to 
high-incidence country will present approximate rates of the new region, indicate that 
environmental and lifestyle factors are important determinants in cancer rates (Willett 2001). 
It is estimated that 25% of the cases are related to hereditary factors while 75% are related to 
other risk factors such as smoking, obesity, sedentarism, aging and dietary habits (Wallace 
& Caslake 2001). The adoption of a western lifestyles and behaviors such as high fat diets, 
physical inactivity and increase in obesity prevalence has been pointed out as one of the 
environmental factors associated with genetic vulnerability that could explain the increase 
in CRC incidence rates in economically transitioning countries (Center, Jemal et al. 2009). 
Diet is definitely a modifiable exogenous influence on etiology of CRC (Labianca & Beretta 
2010). One of the dietary factors suspected of playing a role on the incidence of CRC is fat 
intake. The suspicion that fat intake is related to cancer incidence is resultant from the 
observation that there are large differences in the fat consumption per capita around the 
world and also differences in cancer rates (Willett 1998), however these data are still 
controversial. One of the limitations of epidemiological studies is the fact that they do not 
provide proof of an association between fat and CRC incidence due to measurement error in 
food frequency questionnaire-based dietary assessment, which can cause attenuation of risk 
estimations (Flood, Velie et al. 2003). Many animal studies have shown the importance of 
the type and amount of fat on carcinogenesis (Coleman, Landström et al. 2002; Dwivedi, 
Natarajan et al. 2005; Boateng, Verghese et al. 2006), while studies assessing human dietary 
patterns suggest a decreased risk of CRC associated with a higher frequency of low-fat foods 
(Flood, Rastogi et al. 2008) or a higher risk associated with a western dietary pattern, 
characterized by greater intakes of red and processed meats, sweets and desserts, high-fat 
dairy foods, french fries and refined grains (Fung, Hu et al. 2003). Thus, public health 
campaigns promoting healthier dietary patterns are one of the measures that should be 
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taken to help prevent cancer (Jemal, Bray et al. 2011). Thus, understanding how fats, more 
specifically fatty acids, can play a role in carcinogenesis, must be considered to direct these 
public health campaigns to prevent increases in cancer incidence. 
3. Production, intake and oils composition  
From an evolutionary perspective, the combination of our ancient genome with the 
nutritional qualities of recently introduced foods may underlie many chronic diseases of 
western civilization, including cancer (Cordain & Eaton 2005). One of the main changes in 
the human diet refers to the type and quantity of fatty acids and antioxidant content of 
foods. In the last 20 years, significant changes have occurred in the consumption of lipid 
sources, with reduction of animal fat intake and increase in the intake of vegetable oils 
(Simopoulos 2008). 
The advent of the oil-seed processing industry significantly raised the total intake of refined 
vegetable oils. During the period from 1909 to 1999 there was a significant increase in the 
use of these oils, representing roughly 17.6% of energy intake in the western diet. This 
resulted in a direct increase in the level of -6 polyunsaturated fatty acids (PUFAs) at the 
expense of a lowered level of -3 PUFA since vegetable oils are inherently richer in the first 
(Cordain & Eaton 2005). The utilization of grains in animal diets and oil hydrogenation has 
also contributed to the increased level of linoleic acid (LA, 18:2, -6) in the diets 
(Simopoulos 2008). 
The major oilseeds supplied and distributed around the world are copra, cottonseed, palm 
kernel, peanut, rapeseed, soybean and sunflower seed. The soybean, from a commodity 
viewpoint is number one in terms of production, importation and exportation, while for the 
production of vegetables oils it is the second seed most used, behind palm oil (Figure 1). 
Soybean oil is the second most consumed oil, and from 2006 to 2011 its consumption 
increased by 17.8%. The main countries consuming vegetable oils are China, EU-27, India, 
US, Indonesia and Brazil (Figure 2), and soybean oil is particularly most consumed in China, 
US, Brazil, India, EU-27 and Argentina (Figure 3).    
The hallmark of the increase in oilseed consumption relates to the changes in the 
proportion of fatty acids in the diet. The main fatty acids in concern are from -3 and -6 
family. Alpha-linolenic acid (ALA, 18:3 -3; found in oils, nuts, seeds), eicosapentaenoic 
acid (EPA, 20:5 -3) and docosahexaenoic acid (DHA, 22:6 -3) are members of -3, these 
last two mainly found in animal sources (such as fish, fish oil), while the most common 
fatty acids from -6 family are LA (mainly vegetable sources) and arachidonic acid (AA, 
20:4 -6; mainly from animal sources) (Roynette, Calder et al. 2004; Russo 2009). In a 
typical American diet, 89% of the PUFA consumed is LA, while 9% is ALA, being that 
vegetable oils are the main sources of both. This large difference between -6 and -3 
fatty acids in the western diet is implicated in the increase of the -6:-3 ratio, especially 
when fish and fish oil intake is low. On the other hand, in Europe over the last two 
decades a 50% increase in LA intake has been observed (from 10 to 15g/day) and a 100% 
increase in ALA (from 1 to 1.9g/day) (Russo 2009), reducing this ratio. According to 
Russo (2009), the proportion 1:1 (-6: -3) presumed to be consumed by ancient 
civilization has been replaced by 15:1 - 20:1 in some moderns civilizations of western 
regions (Simopoulos 2008).  
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Fig. 1. Major vegetable oils produced (million metric tons) from 2006 to January (J) and 
February (F) of 2011 (Source: USDA).  
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Fig. 2. Domestic consumption of major vegetable oils (million metric tons) from 2006 to 
January (J) and February (F) of 2011 (Source: USDA).  
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Fig. 3. Domestic consumption of soybean oil (thousand metric tons) from 2006 to January (J) 
and February (F) of 2011 (Source: USDA).  
Considering the economic importance and the high dietary intake of soybean oil, it should 
be discussed its composition in comparison with other oils of importance in human 
nutrition (Table 1). The major fatty acid in sunflower, soybean and corn oils is the LA. The 
canola oil has approximately 21% of LA, while palm, flaxseed, olive oil have less than 16%, 
and fish oil less than 3%. Vegetables oils only present -3 in the form of ALA. Flaxseed has a 
high level of ALA (more than 50%), while the other oils has less than 7%. The soybean and 
canola oil have similar quantities of ALA and the highest content after flaxseed, showing 
levels 7-21 fold higher in comparison to other oils than flaxseed. The palm oil, is together 
with soybean oil, the most consumed oil, but it should be highlighted that it has 3 to 4-fold 
more saturated fatty acids in comparison with other vegetable oils, what may be a 
disadvantage considering the role of saturated fats on cardiovascular risks. The fish oil, 
although is from animal source, is included in this table because is the only source of oil 
directly providing EPA and DHA, which accounts for more than half of its fatty acid 
composition. Its ALA content is low and soybean oil has 8 times more ALA than fish oil. 
4. Importance of PUFAs in human nutrition 
The effects of oils and fats in human nutrition have been largely discussed in the last 
decades, emphasizing the reduced intake of saturated and trans fatty acids and the increase 
in -3 intake (Wortman, Miyazaki et al. 2009).  
ALA and LA are considered essential because they are not synthesized in the human body 
due to the lack of enzymes capable of inserting double bonds in the third and sixth carbons 
counted from the methyl terminal (Roynette, Calder et al. 2004). The LA is converted into 
AA. In mammals, the essential fatty acids ALA can be converted to EPA and DHA, but the 
endogenous rate of conversion is unknown. It is believed that this conversion might be low, 
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approximately 5-10% of the ALA is converted to EPA and 2-5% to DHA in healthy adults 
(He 2009). 
 
Fatty 
Acids 
 Concentrationsa 
 
Soybean 
oil (1) 
Corn 
oil (2) 
Sunflower
oil (2) 
Canola
oil (2) 
Palm 
oil(2) 
Olive 
oil (1) 
Flaxseed 
oil (1) 
Fish 
oil (1) 
C14:0  ND ND 0.07 0.06 0.79 ND ND 5.86 
C15:0  ND ND ND ND ND ND ND 0.22 
C16:0  7.75 12.12 6.10 4.59 36.77 11.30 6.45 10.76 
C17:0  ND ND ND ND ND ND ND 0.50 
C18:0  3.01 2.18 3.42 2.21 4.61 2.96 4.35 3.60 
C20:0  ND 0.49 0.26 0.57 0.35 0.38 ND 0.48 
C22:0  0.34 0.18 0.67 0.30 0.10 0.12 ND ND 
C24:0  ND 0.19 0.25 0.15 0.08 ND ND ND 
 AGS  11.10 15.20 10.80 7.90 43.1 14.70 10.80 21.42 
C16:1  ND 0.12 0.08 0.2 0.14 1.09 ND 6.60 
C18:1 -9  21.36 33.04 25.15 61.14 39.86 74.01 18.00 9.98 
C20:1  ND 0.23 0.18 1.11 0.24 0.25 ND 1.08 
 MUFA  21.36 33.4 25.4 62.6 40.1 75.35 18.00 17.66 
C20:2  ND ND ND ND ND ND ND 3.05 
C18:2 -6  60.75 49.94 62.22 20.87 15.69 8.74 12.71 2.78 
C20:4 -6  ND ND ND ND ND ND ND 0.73 
C22:2 -6  ND ND ND ND ND ND ND 0.87 
C18:3-3  6.96 0.96 0.32 6.78 0.83 0.75 58.47 0.80 
C20:5-3  ND ND ND ND ND ND ND 24.01 
C22:6 -3  ND ND ND ND ND ND ND 19.86 
 PUFA  67.71 50.90 62.6 28.4 16.6 9.50 71.18 52.10 
Total-6  60.75 49.94 62.22 20.87 15.69 8.74 12.71 4.37 
Total-3  6.93 0.96 0.32 6.78 0.83 0.75 58.47 44.63 
-6/-3  8.77 52.0 195.0 3.01 18.9 11.65 0.22 0.10 
aFatty acid concentration in soybean, corn, sunflower, canola, olive, flaxseed and fish oils. The 
identification of the methyl esters of the fatty acids was performed by gas chromatography. Values are 
in g/100 g. *ND= not determined.  Source: (1) (ROSA, SALES et al., 2010) (2) (TACO, 2006).   
Table 1. Concentration of fatty acids in the oils used in the diets (percent).  
The importance of PUFAs in human nutrition relates to their role in modulating 
inflammatory responses, which in turn is related to immunological resistance, metabolic 
disturbances, thrombotic events and neoplasia (Martin, Almeida et al. 2006; Hirayama, 
Speridião et al. 2006). The -6 and -3 fatty acids are not metabolically interconvertable but 
because both share enzymatic pathways and usually play opposite effects, their balance or 
proportion seems to be important (Whelan & McEntee 2004).  
According to Willet (2001), non-cancer outcomes can aid in interpreting findings for cancer, 
especially when an association is observed with coronary heart disease, and any actual 
dietary decisions should be made in the light of not just cancer, but how dietetic variables 
relate to cardiovascular disease (CVD) and other important conditions. Evidences suggest 
that when increasing -3 intake (EPA and DHA), the incidence of CVD is reduced, but 
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opinions are still divergent on whether the same effects can be obtained with the reduction 
of -6 intake. It is worthy to note that there are ethnic differences in the percentage of deaths 
from CVD when comparing Europe and the US (45%) with Japan (12%) which are 
coincident with significant differences in platelet phospholipid EPA concentration (0.5% vs 
1.6%), while AA concentration is similar (26% vs 21%) (Russo 2009). Thus, the moderate 
consumption of fatty acids from the -3 family, especially from fish oil, plays an important 
role on the reduction of CVD risks. Considerable attention has been directed to evaluate the 
action of ALA, EPA and DHA in the prevention and treatment of diseases in general. The 
American Heart Association (AHA) recommends the use of 1g/day of -3 (EPA plus DHA) 
from fish oil or fatty fish to patients with CVD (Lavie, Milani et al. 2009). 
In 2007,  Von Schacky and Harris proposed the “-3 index” as a new risk factor for cardiac 
disease. This index is defined as the percentage of EPA plus DHA of the total fat content in 
erythrocytes, reflecting the individual -3 status. Although the authors have shown 
evidences that support the clinical efficacy of this index, it hasn’t been validated as a 
biomarker. The PUFA content in cell membranes depends on diet content and its proportion 
of -6 and -3 fatty acids, although an optimal proportion still hasn’t been established (von 
Schacky & Harris 2007). 
5. PUFAs and colorectal carcinogenesis 
Biological effects on CRC promotion by -6 PUFA or suppression by -3 PUFA has been 
suggested by experimental and epidemiological studies (Nkondjock, Shatenstein et al. 2003; 
Moreira, Sabarense et al. 2009; Rosa, Sales et al. 2010; West, Clark et al. 2010). These effects 
include alteration in properties of cancer cells (proliferation, invasion, metastasis, and 
apoptosis) and host cells (inflammation, immune response and angiogenesis) (Larsson, 
Kumlin et al. 2004; Roynette, Calder et al. 2004). 
These effects are mediated by various mechanisms. It has recently been shown that 
polymorphisms in fatty acid metabolism-related genes are associated with CRC risk. 
Although their contribution to CRC is not fully explained, they reinforced the key role of 
eicosanoid signaling in colon carcinogenesis (Hoeft, Linseisen et al. 2010). These eicosanoids 
are end-products of cell membrane fatty acids mobilization. The PUFA, LA and ALA are 
mobilized from cell membrane phospholipids through the action of phospholipases A2 and 
C enzymes. They then compete for desaturases and elongases enzymes for conversion to 
their metabolites, AA and EPA respectively. These enzymes have a greater affinity for -3 
fatty acids, such that -3 are preferentially metabolized when its intake in the diet is high. 
This leads to a “competitive inhibition” of -6 PUFA metabolism, decreasing LA 
desaturation and AA concentration after ALA, EPA or DHA supplementation. On the other 
hand, increases in -6 will reduce EPA and DHA conversion (Roynette, Calder et al. 2004).   
After mobilization from the cell membrane and AA or EPA formation, these fatty acids are 
subsequently metabolized into eicosanoids by the action of cyclooxygenase (COX) and 
lipoxygenase (LOX). Eicosanoids such as prostanoids (prostaglandins and thromboxanes), 
and leukotrienes are potent modulators of inflammatory and immune responses playing a 
critical role on platelet aggregation, cellular growth and differentiation. The COX action 
results in prostaglandins and thromboxanes, while the LOX produces leukotrienes. 
Eicosanoids are derived from fatty acids with 20 carbon atoms such as AA and EPA 
(Larsson, Kumlin et al. 2004; Berquin, Edwards et al. 2008), a step where there is also 
another competition among PUFA where there is a greater affinity for the -3 PUFA. Thus, 
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EPA is preferentially metabolized and consequently eicosanoids from series 3 
(prostaglandins and thrombaxanes) and 5 (leukotrienes) will be produced. The proportion 
of PUFA in the cell membranes is the main factor regulating which eicosanoids will be 
produced, and this proportion reflects the amount of PUFA present in the diet (Rose & 
Connolly 1999; Moreira, Sabarense et al. 2009; Russo 2009).  
Increase in -6 fatty acids in the western diet contributes to greater production of 
eicosanoids from AA rather than from EPA, which are associated with an decreased  rate of 
apoptosis and a increased tumoral growth, and are also more reactive compared to pro-
inflammatory eicosanoids derived from EPA (Roynette, Calder et al. 2004); eicosanoids from 
AA are biologically active even in small amounts. Lee et al. (1984) demonstrated that 
leukotriene B5 has only 5 to 10% of the activity of leukotriene B4 (from AA). If AA 
eicosanoids are formed in greater quantities, especially with a diet rich in -6 fatty acids, it 
shifts the physiological state to a prothrombotic, proaggregation and pro-inflammatory 
condition (Simopoulos 2008), while the increase in -3 intake could result in the reduction of 
the pro-inflammatory state (West, Clark et al. 2010). 
As eicosanoid production influences carcinogenesis, the isoform of the enzyme producing 
them also play a role. There are two isoforms of COX: COX-1, which is constitutively 
expressed in many tissues, and COX-2, which is the inducible form. COX-2 expression 
occurs in most tissues, but after stimulus its expression can increase considerably (Zha, 
Yegnasubramanian et al. 2004). Elevated levels of COX-2 have been observed in colon 
tumors in humans and animals by chemically induced carcinogenesis (Shao, Sheng et al. 
1999; Ceccarelli, Piazzi et al. 2005). This increase in COX-2 indicates an increase in the 
capacity to produce prostaglandin E2 (PGE2) in the presence of AA. The PGE2 can promote 
carcinogenesis through the inhibition of apoptosis, induction of cell proliferation and 
angiogenesis (Leahy, Ornberg et al. 2002; Pai, Nakamura et al. 2003).  Singh et al. (1997) 
induced CRC in rats and found elevation of COX-2 expression in the group treated with 
corn oil compared to the group receiving fish oil, indicating that -6 rich oils participates in 
this mechanism. 
A significant correlation was found between inducible nitric oxide synthase (iNOS) enzyme 
and COX-2 expression. The PGE2 production also correlated with iNOS activity (Cianchi, 
Cortesini et al. 2004). The iNOS is responsible for the synthesis of nitric oxide (NO) from L-
arginine. The NO mediates intra and extracellular processes; however, it is potentially toxic 
since it can react with oxygen or superoxides, damaging tissues and DNA. The activation of 
iNOS and the subsequent excess of NO production can also inhibit the activity of enzymes 
related to DNA repair and modulate caspases and p53 activity (Jaiswal, LaRusso et al. 2000). 
A significant correlation was found between iNOS and COX-2 expression. The PGE2 
production also correlated with iNOS activity (Cianchi, Cortesini et al. 2004). Another 
correlation found was between iNOS and angiogenesis in patients with CRC (Cianchi, 
Cortesini et al. 2003). Narayanan et al. (2003) showed that DHA can reduce iNOS expression 
in vitro. Reduction of the endogenous level of -6 PUFA is beneficial since lower expression 
of the iNOS enzyme and increased expression of the transforming growth factor beta (TGF-
) in transgenic animal model chemically submitted to CRC was observed (Nkondjock, 
Shatenstein et al. 2003). Reduction of TGF-  expression has been shown to significantly 
increase chemically-induced colon carcinogenesis (Tang, Böttinger et al. 1998). On a 
molecular level, TGF- was shown to inhibit transformation through inhibition of the Akt 
pathway in intestinal epithelial cells (Cao, Deng et al. 2006). Therefore, -6 fatty acids again 
appear to exert a negative influence on induction of enzymes related to carcinogenesis and 
reduction of protective molecules. 
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The -6 and -3 PUFAs can also influence colorectal carcinogenesis by affecting expression 
of genes associated with vital functions of the cell, enzymes activities and signal 
transduction molecules. Cellular proliferation (mitosis) and growth are important aspects of 
tumors development when they occur uncontrolled. In this situation, the induced cell death 
through  apoptosis  is activated, which is recognized as an anti-carcinogenesis mechanism. 
When this mechanism fails, tumors can develop (Arlt, Müerköster et al. 2010). 
The activated Ras protein regulates mitosis, and its increased expression is related to tumor 
development (Mangues, Seidman et al. 1992). Diets containing greater proportions of -6 
(corn oil) increases the expression of Ras protein by 13% in the colonic mucosa of rats treated 
with azoxymethane in comparison to animals receiving a diet rich in -3 (fish oil) 
(Davidson, Lupton et al. 1999). Cellular growth can be promoted by insulin-like growth 
factor (IGF) through autocrine and paracrine actions, and IGF binding proteins (IGFBP) 
modulate IGF actions. Increases in IGF-II expression was demonstrated in patients with 
CRC (Freier, Weiss et al. 1999), while treatment of Caco-2 cells with EPA or DHA reduced 
IGF-II secretion and increased IGFBP-6 secretion, inhibiting cellular proliferation. On the 
other hand, LA can increase the level of IGF-II without altering IGFBP-6 secretion and 
stimulate Caco-2 cell proliferation (Kim, J. et al. 2000). It has also been suggested that 
hyperinsulinemia and insulin resistance can play a significant role in CRC etiology 
(Trevisan, Liu et al. 2001; Ma, Giovannucci et al. 2004). Insulin acts as growth factor for 
colonic cells because it enhances IGF-I activity, cell proliferation and differentiation, and 
inhibits apoptosis (Biddinger & Ludwig 2005; Giovannucci 2007). Smith et al. (2010) 
demonstrated that reduction of the -6:-3 ratio can increase glucose tolerance and improve 
insulin sensitivity in healthy animals. 
Meanwhile, the expression of some proteins related to apoptosis can be beneficial. The type 
of oil, and consequently its fatty acid profile, can exert different influences on protein 
expression. Cancerous cells usually overexpress Bcl-2 proteins involved in apoptosis 
inhibition (Bronner, Culin et al. 1995 ), so that reduced expression could be beneficial. In 
cultured human cancer cells (Caco 2 and HT-29) supplemented with olive oil, fish oil, oleic 
fatty acid and LA, it was verified that Bcl-2 expression was reduced in cells supplemented 
with EPA and DHA (fish oil group) (Llor, Pons et al. 2003). Moreover, Cheng et al. (2003) 
found an elevation in Bax protein expression, associated with the increase in apoptotic cell 
activity in individuals with CRC who consumed greater quantities of fish oil. Signaling 
molecules such as the transcriptional factor NF have been shown to play a role in 
carcinogenesis once it regulates the expression of genes involved in migration, proliferation 
and apoptosis (Dolcet, Llobet et al. 2005). Reduction of the endogenous level of -6 PUFA 
led to lower NF activity in transgenic animal models chemically submitted to CRC 
(Nowak, Weylandt et al. 2007). Ravasco et al. (2009) also observed that patients with 
elevated intake of -6 PUFA, saturated fat, animal protein, refined carbohydrates and 
alcohol – a typical western diet – present greater expression of this transcriptional factor. 
However, patients with higher -3, fibers, vitamin E, isoflavonoid, -carotene and selenium 
intake showed reduced NF expression. 
Another mechanism that links apoptosis, PUFA and CRC development refers to the 
peroxisome proliferator-activated receptor (PPAR). DHA and EPA (in lesser extent) can 
inhibit PPAR- which is associated with the increase in cell proliferation and apoptosis 
suppression (Lee & Hwang 2002; Lund 2006; Wang & DuBois 2008). On the other hand, Xu 
et al. (2006) demonstrated that AA can act as an activator of PPAR-. Thus, sources of -6 
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fatty acids appear to be disadvantageous for cancer prevention while -3 fatty acids are 
beneficial. 
The PUFA have also demonstrated to influence the activity of the enzyme ornithine 
decarboxylase (ODC), which is a limiting enzyme in polyamines synthesis (putrescin, 
spermidin and spermine). These polyamines are involved in cellular growth, renewal and 
metabolism, and have been found in high concentrations in colorectal tumors of rats treated 
with dimethylhydrazine and humans due to increased ODC activity (Lamuraglia, Lacaine et 
al. 1986; Shigesawa, Onoda et al. 1998). Bastram et al. (1993) observed a reduction in ODC 
activity in the colon of healthy individuals consuming fish oil compared with corn oil (rich 
in LA). Rao and Reddy (1993) encountered results reinforcing the role of -3 fatty acids from 
fish oil in suppressing ODC activity in animal models of carcinogenesis in comparison to -
6 fatty acids from corn oil.   
It can be highlighted that the suppressive effects of EPA and DHA on CRC tumors are 
consistently verified, while ALA effects are still controversial (Daniel, McCullough et al. 
2009). This inconsistency can be related to the small conversion of ALA to EPA, which 
requires further investigations (Berquin, Edwards et al. 2008). In relation to the adverse 
effects from -3 PUFA intake, it is important to highlight that these fatty acids present a 
greater number of double bonds (unsaturations) which makes cell membranes more 
susceptible to lipid peroxidation. Thus, it is recommended to increase the intake of 
antioxidant vitamins to compensate for the increase in PUFA intake, mainly -3, in order to 
stabilize the double bonds (Institute of Medicine 2000). 
However, it is not correct to consider that all mediators formed from AA are pro-
inflammatory while those formed from EPA are always less potent. The action of -6 and -
3 fatty acids and their derivatives on inflammatory processes can actually involve more 
complex mechanisms than those already recognized and requires more studies to clarify 
their mechanisms and effects (Calder 2009). 
6. PUFA intake recommendations 
The -3 long chain fatty acids (LCFA), EPA and DHA, have received special attention as a 
recommended nutrient for secondary prevention of CVD and for the prevention and 
treatment of disorders with an inflammatory component (including type 2 diabetes, irritable 
bowel syndrome, macular degeneration, rheumatoid arthritis, asthma, several cancers, and 
psychiatric disorders) since these illnesses have shown to be a problem around the world 
(Hibbeln et al, 2006). The high -6:-3 ratio is unfavorable, especially in health conditions 
characterized by aggravation of the inflammatory response  (Garófolo & Petrilli 2006). There 
are some studies associating PUFAs and CRC in humans suggesting a possible protective 
role of -3 in this disease (Table 2). 
Establishing healthy -6 and -3 intakes is difficult since there are various factors 
influencing optimal intake. Hibbeln et al. (2006) discussed these aspects in an ecological 
study design. Some of their considerations are very important to be discussed in this chapter 
to aid in answering whether soybean oil has a positive or negative health effects in 
comparison with other oils. 
1. A tissue composition of 60% -3 LCFA may prevent 98.6% of the worldwide risk of 
cardiovascular mortality potentially attributable to -3 LCFA deficiency. However, the 
-3 LCFA intake required to achieve 60% -3 fatty acids in tissue varied 13-fold among 
nations depending on essential fatty acid availability. In general, as concurrent LA 
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availability increased, the estimated requirement for -3 LCFA intake increased, 
although intake of ALA and AA also played a role. For Americans consuming a 2000-
kcal/d diet, 2178 mg/d (0.98% of energy) may achieve 50% -3 LCFA in tissue, whereas 
3667 mg/d is necessary to reach 60% -3 LCFA. 
2. Available intake of -3 LCFA to provide 0.34% of energy was sufficient to reduce risk 
for 98% of the mortality and morbidity in all illness models.  
3. Lowering LA intake can likely decrease an individual’s need for -3 LCFAs by one-
tenth.  
4. Concurrent dietary intakes of LA, AA, ALA, EPA and DHA should be considered in 
predicting final tissue proportions of -3 LCFAs. Thus, a healthy dietary intake of -3 
LCFA must be dependent on concurrent intakes of LA, AA and ALA. A healthy dietary 
allowance of 3.5 g EPA plus DHA/d, which is based on the current per capita available 
intake of -6 fatty acids and ALA in the US, could be reduced to one-tenth of that 
amount if the intake of -6 fatty acids, in particular LA, can be lowered to 2% of the 
total energy. 
Based on a critical analysis of available literature, Wijendran and Hayes (2004) suggest for 
health adults an adequate intake of about 6% of total calories from LA, 0.75% from ALA, 
and 0.25%–0.5% for EPA plus DHA. This corresponds to an -6:-3 ratio of 6:1. According 
these authors, intake of PUFA expressed in terms of mass (% kcal or g/d) is a better 
approach to dietary -6 and -3 fatty acid balance than a simple ratio. 
Therefore, choosing the best oil to cook or to add in food products should consider its lipid 
profile and how much of it is used.  
 
Reference Study  Design 
Comparative 
Indicator 
Results 
Linoleic  Acid (LA, -6) 
Tuyns et al. 
(1987) 
Case-control 
818 cases/2851 controls Food Intake 
Inverse association 
between LA and cancer 
 
Bar et al. (1998) Cross-sectional 
17 cases /12 controls 
Fatty acids in 
plasma 
Significant   LA  in 
cancer patients 
 
Terry et al. 
(2001) 
Cohort – Sweden 
61463 women 
Food Intake 
No relationship 
 
Astorg (2005) Meta Analysis
Epidemiological research Food Intake 
No relationship 
 
 
Hall et al. (2007) Case-Control (Physicians' 
Health Study). 178 case 
men/282 control men 
Blood Levels 
No relationship 
 
 
 
Theodoratou et 
al. (2007) 
Prospective case-control 
study 1455 cases/ 1455 
controls 
 
Food Intake 
No relationship 
Murff et al. 
(2009) 
Cohort Study (Study 
Shanghai Women's Health) 
73242 woman 
Food Intake 
No relationship 
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Reference Study  Design 
Comparative 
Indicator 
Results 
 
-Linolenic Acid  (ALA , -3) 
Fernández-
Bañares et al. 
(1996) 
Cross-sectional 
49 CRC cases /12 controls Mucosal fatty 
acids 
Significant    ALA in 
intestine mucosal of 
cancer patients 
 
Bar et al. (1998) Cross-sectional 
17 CRC cases /12 controls 
 
Fatty acids 
Significant   ALA  in 
plasma of cases 
 
Nkondjock et al. 
(2003) 
Case-control 
402 cases/668 controls Food Intake 
Significant inverse 
association between 
ALA and CRC 
 
Terry et al. 
(2001) 
Cohort (1987-1990) 
61463 women 
 
Food Intake 
No relationship 
Astorg (2005) Meta Analysis 
Epidemiological Research 
 
Food Intake 
No relationship 
Theodoratou et 
al. (2007) 
Prospective case-control 
study 1455 cases/1455 
controls 
 
Food Intake 
No relationship 
Murff et al. 
(2009) 
Cohort Study (Study 
Shanghai Women's Health) 
73242 women 
 
Food Intake 
No relationship 
Eicosapentaenoic acid  plusDocosahexanoic Acid (EPA/DHA , -3) 
Jiang et al. 
(2010) 
Randomized clinical trial 
Intravenous infusion of 
soybean oil or fish oil 
203 cases 
 
Inflammatory 
response and 
lenght of hospital 
stay 
Significant   in fish oil 
Hall et al. (2007) Case-Control (Physicians' 
Health Study) 178 case/282 
control (men) 
Blood Levels 
EPA and DHA were 
inversely associated 
with CRC risk 
Theodoratou et 
al. (2007) 
Prospective case-control.1455 
cases/ 1455 controls 
Food Intake 
Significant   in the risk 
were associated 
with   EPA and DHA 
intake 
 
Kin et al. (2010) Case-control 
929 cases/943 controls Food Intake 
Inverse association 
between EPA, DHA and 
CRC 
 
Gee et al. (1999) Case-control 
14 cases/14 controls 
 
Colorectal 
cytokinetics 
No relationship 
Terry et al. Cohort-Sweden (1987-1990), Food Intake No Relationship 
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Reference Study  Design 
Comparative 
Indicator 
Results 
(2001) 61463 women 
 
Astorg (2005) Meta Analysis 
Epidemiological research 
 
Food Intake No relationship 
Murff et al. 
(2009) 
Cohort (Study Shanghai 
Women's Health), 73242 
women 
 
 
Food Intake No Relationship 
Oh et al.(2005) Cohort (Nurses’ Health 
Study) 34451women 
 
Food Intake No relationship 
Eicosapentaenoic acid  (EPA, -3) 
 
Fernández-
Bañares et 
al.(1996) 
Cross-sectiiional 
49 cases CCR/12 controls 
Mucosal Fatty 
acids 
Significant   in 
intestine mucosal EPA 
content in cancer 
patients 
 
Courtney et 
al.(1996) 
Case-control 
14 cases/14 controls 
Apoptosis and 
crypt cell 
proliferation 
 
Significantly   in 
cancer patients 
Hall et al.(2008) 
Prospective Study 
(Physicians’ Health Study), 
500 men 
 
Food Intake 
EPA significantly  the 
risk for CCR 
West et al.(2010)
Clinical Trial 
55 patients 
The number and 
size of polyps 
Protective effect of EPA 
in colon  cancer patients 
 
Docosahexanoic Acid (DHA , -3) 
 
Kuriki et 
al.(2006) 
Case-control 
74 cases/221 controls 
Erythrocyte fatty 
acids 
Inverse association 
between erythrocyte 
compositions and DHA 
 
Hall et al.(2007) 
Case-Control (Physicians' 
Health Study), 178 
case/282control 
 
Blood Levels 
DHA were inversely 
associated with CRC 
risk 
Table 2. Human studies examining the effect of -6 and -3 PUFAs on colorectal cancer risk 
7. Future perspectives 
Sufficient evidence was shown to portray the shift in concern on the role of dietary fat in 
carcinogenesis: from the amount of fat consumed to the type of fat (fatty acids profile), that 
is, -3 vs -6 PUFAs. Most evidence for benefits apply to the -3 LCFAs. Considering this, 
two problems are indicated: western diets are typically low in EPA and DHA because 
consumption of the primary source of these fatty acids from oily fish (such as salmon, 
mackerel, albacoretuna, and sardines) is low (Harris, Lemke et al. 2008) and it is problematic 
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to recommend to patients or the community to increase fish intake due to price and 
availability of oily fish (James, Ursin et al. 2003). Because conversion of dietary ALA into 
EPA is limited and a fish/fish oil based diet is not easily adopted, dietetic solutions to this 
limitation should provide great perspectives for the future. 
Some vegetables oils are good sources of -3, such as canola and linseed oils, but in the ALA 
form. However, conversion of ALA to EPA is inefficient in adult humans and increased 
intake of ALA does not reproduce the health benefits of -3 LCFAs.  Initially, it is generally 
assumed that LA reduces EPA synthesis because of the competition between ALA and LA 
for common desaturation and elongation enzymes. Hence, one of the dietetic solutions 
thought to favor the conversion of ALA into the -3 LCFA would be the increase of ALA 
intake or decrease of LA intake. Goyens et al. (2006) designed a nutritional intervention trial 
to determine whether in vivo conversion of dietary ALA is influenced by the absolute 
amounts of LA or ALA in the diet or by the ALA-to-LA ratio. They concluded that ALA and 
LA content in the diet, and not its ratio, determines the conversion of ALA into EPA/DHA, 
suggesting that the increase in DHA is directly related to ALA content in the diet, while 
EPA formation is favored by reduced LA levels in the diet (Goyens, Spilker et al. 2006). 
Besides reducing dietary intakes of the 18-carbon precursor, LA lowers the available tissue 
composition of AA. According to Hibbeln et al. (2006), it is likely that the success and failure 
of different clinical trials using similar doses of -3 LCFAs may have been influenced by 
differing background intakes of the -6 LA and AA fatty acids. The biological availability 
and activity of -6 LCFAs, in particular AA, is inversely related to -3 LCFAs in tissue. 
Greater compositions of EPA and DHA in membranes competitively lower the availability 
of AA for the production of inflammatory eicosanoids. 
A useful land-based dietary resource for increasing tissue concentrations of -3 LCFAs in 
humans would be of great economical interest to provide a wide range of dietary 
alternatives to fish and encapsulated fish oil supplements to increase tissue concentrations 
of -3 LCFAs without altering common dietary habits.  Stearidonic acid (SDA, 18:4 -3) rich 
oils could provide this potential land solution, since it has also been studied as a precursor 
for -3 LCFAs in humans. SDA is an intermediate metabolite between ALA and EPA in the 
-3 biosynthetic pathways. It has been shown that ALA in the diet is converted to EPA, with 
only a fraction of the efficiency of SDA in healthy subjects (James, Ursin et al. 2003). Further, 
-6 activity has been shown to decline with age (Bourre, Piciotti et al., 1990) and with a 
significant number of clinical conditions, such as cancer, making utilization of dietary ALA 
even less efficient (Damude & Kinney 2008). 
Recently, soybean plants have been genetically modified to produce oil containing a 
substantial amount of SDA (15-30% w/w of total fatty acids) with value in both food and 
feed applications (Ursin 2003). Some studies are consistent with the premise that 6 
desaturation is the rate-limiting step in the conversion of ALA to EPA and that SDA has a 
biochemical advantage over ALA in elevating the levels of others -3 LCFAs in tissues. The 
efficiency of ALA conversion into EPA was shown to be 0.09%, while SDA conversion was 
16.6% (relative to EPA). Hence, another strategy for raising tissue EPA levels with a plant-
based -3 is to consume foods containing SDA (Harris, Lemke et al. 2008). James et al. (2003) 
showed greater enrichment of EPA in plasma and lipid cells if subjects supplemented their 
diet with ethyl ester of SDA than if supplemented with the same amount of the ethyl ester of 
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ALA. Therefore, SDA appears to be superior to ALA for increasing -3 LCFAs status in 
humans and thus sources of SDA might offer some human health benefits. Supplementation 
of SDA led to an elevated increase in EPA compared to ALA supplementation, but no 
increase in DHA. SDA also demonstrated to be superior to ALA for lowering the level of 
COX-2 protein and mRNA expression in breast cancer cells. Thus, the authors suggested 
that dietary SDA may be more beneficial than ALA in reducing the risk of breast cancer by 
effectively antagonizing PGE2 production from AA (Horia & Watkins 2005). 
It should be highlighted that the effectiveness of SDA as a nutritional fatty acid is dependent 
on the ability of humans and animals to convert SDA to EPA and DHA. Thus, the beneficial 
effects of EPA and DHA have incentivated the development of soybean seeds that accumulate 
oils with EPA and DHA. It is envisioned that these oils can be produced at a lower cost in 
soybean seeds compared with fish and algae, the current commercial sources of EPA and 
DHA-containing oils. Additionally, soybean offers a more sustainable production platform 
than fish. It is likely that soybean oil enriched in EPA and DHA is used in the manufacture of 
food and feed products, including salad oils, infant formulas, and feed rations for farm fish 
(Clemente & Cahoon 2009). Thus, in relation to soy, the future strides in making a better bean. 
8. Conclusion  
Cancer, as said before, is a multifactorial disease. To blame fat as the only factor behind 
colorectal carcinogenesis would be irresponsibility, but it plays an important role in etiology 
for which public health campaigns and food manufacturers can discuss possible changes to 
benefit all.  
Human studies evaluating dietary pattern to estimate risk factors are frequently difficult to 
interpret since individuals with healthier dietary patterns also present other healthier 
behaviour. On the other hand, experimental studies have contributed to comprehension of 
the relation between PUFAs and CRC and demonstrate that lower cancer progression is 
influenced by -3 intake, mainly LCFA, while a higher progression is related to elevated -6 
intake. Thus, the ideal dietetic solution for a westernized dietary pattern would be the 
combination of an increase in -3 LCFA and reduction of -6 PUFA. More discussions 
regarding what unit to use to recommend fatty acid intake (% of calories, g/d or -6:-3 
ratio) should take into consideration the results of controlled studies. 
If we consider that overconsumption of oils rich in -6 can favour a pro-inflammatory state 
and predispose to the development of chronic diseases, such as CRC, sunflower oil, 
followed by soybean and corn oils are not the best type of oil to be used for cooking or 
added to food products. On the other hand, if we look to the -3 level, soybean oil is similar 
to canola oil and superior than corn, sunflower and olive oil. The -3 content of flaxseed and 
fish oil is so high that makes them inadequate for cooking or as food ingredient due to 
higher susceptibility to oxidation and formation of undesirable flavor.  Considering this and 
the -6:-3 ratio in the others more usable oils, soybean oil would be the best choice for 
cooking after canola oil, even better if we take into account soybean oil prices in comparison 
to others oils.  
Research investments have been made in order to improve fatty acid profile in the soybean 
and consequently in its oil, bringing new perspectives for this discussion. Genetic 
modifications allow that products provide a more balanced fatty acid profile as an 
alternative to the traditional soybean and these studies are under investigation, showing 
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good potential with increased levels of SDA. This modification seems to overcome the main 
limitation of vegetable oils, which is the fact that although they are good sources of -3 in 
the ALA form, the conversion to pharmacologically active compounds (EPA and DHA) is 
low. Besides, there is also a reduction of LA in the SDA rich soybean oil, which may help to 
reduce LA intake and consequently reduce the -3 fatty acid needs. Although this 
genetically modified (OGM) soybean brings good perspectives in a clinical application point 
of view, the disadvantages or risks of using OGM´s from other viewing angles should be 
also considered.  
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